German survey gives rise to optimism in '06
This article was originally published in Clinica
88% of companies in Germany expect operating and economic conditions to be at least as good in the coming year as in 2005. That was one of the findings of a BVMed industry association survey of more than 200 of its company members. 26% of companies have taken on more staff in the last year, the association said, unveiling the data on November 2. The findings give rise to guarded optimism, it said.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.